Logo image of AXTA

AXALTA COATING SYSTEMS LTD (AXTA) Stock Fundamental Analysis

NYSE:AXTA - New York Stock Exchange, Inc. - BMG0750C1082 - Common Stock - Currency: USD

28.79  -1.37 (-4.54%)

After market: 28.79 0 (0%)

Fundamental Rating

6

We assign a fundamental rating of 6 out of 10 to AXTA. AXTA was compared to 85 industry peers in the Chemicals industry. AXTA scores excellent on profitability, but there are some minor concerns on its financial health. AXTA is valued quite cheap, while showing a decent growth score. This is a good combination! These ratings would make AXTA suitable for value investing!


Dividend Valuation Growth Profitability Health

8

1. Profitability

1.1 Basic Checks

AXTA had positive earnings in the past year.
In the past year AXTA had a positive cash flow from operations.
In the past 5 years AXTA has always been profitable.
AXTA had a positive operating cash flow in each of the past 5 years.
AXTA Yearly Net Income VS EBIT VS OCF VS FCFAXTA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M

1.2 Ratios

With an excellent Return On Assets value of 6.06%, AXTA belongs to the best of the industry, outperforming 84.71% of the companies in the same industry.
The Return On Equity of AXTA (21.63%) is better than 90.59% of its industry peers.
Looking at the Return On Invested Capital, with a value of 10.48%, AXTA belongs to the top of the industry, outperforming 85.88% of the companies in the same industry.
Measured over the past 3 years, the Average Return On Invested Capital for AXTA is in line with the industry average of 6.84%.
The 3 year average ROIC (7.99%) for AXTA is below the current ROIC(10.48%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 6.06%
ROE 21.63%
ROIC 10.48%
ROA(3y)3.93%
ROA(5y)3.43%
ROE(3y)16.37%
ROE(5y)15.06%
ROIC(3y)7.99%
ROIC(5y)7.07%
AXTA Yearly ROA, ROE, ROICAXTA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5 10 15 20

1.3 Margins

AXTA has a better Profit Margin (8.56%) than 81.18% of its industry peers.
In the last couple of years the Profit Margin of AXTA has grown nicely.
AXTA has a Operating Margin of 15.73%. This is in the better half of the industry: AXTA outperforms 78.82% of its industry peers.
In the last couple of years the Operating Margin of AXTA has grown nicely.
AXTA has a Gross Margin of 34.36%. This is in the better half of the industry: AXTA outperforms 68.24% of its industry peers.
AXTA's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 15.73%
PM (TTM) 8.56%
GM 34.36%
OM growth 3Y8.8%
OM growth 5Y3.79%
PM growth 3Y7.44%
PM growth 5Y5.93%
GM growth 3Y1.74%
GM growth 5Y-0.48%
AXTA Yearly Profit, Operating, Gross MarginsAXTA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10 20 30

5

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is just above the Cost of Capital (WACC), so AXTA is still creating some value.
Compared to 1 year ago, AXTA has less shares outstanding
Compared to 5 years ago, AXTA has less shares outstanding
The debt/assets ratio for AXTA has been reduced compared to a year ago.
AXTA Yearly Shares OutstandingAXTA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M
AXTA Yearly Total Debt VS Total AssetsAXTA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B

2.2 Solvency

An Altman-Z score of 2.39 indicates that AXTA is not a great score, but indicates only limited risk for bankruptcy at the moment.
AXTA has a better Altman-Z score (2.39) than 65.88% of its industry peers.
The Debt to FCF ratio of AXTA is 8.40, which is on the high side as it means it would take AXTA, 8.40 years of fcf income to pay off all of its debts.
The Debt to FCF ratio of AXTA (8.40) is better than 67.06% of its industry peers.
AXTA has a Debt/Equity ratio of 1.64. This is a high value indicating a heavy dependency on external financing.
AXTA has a Debt to Equity ratio of 1.64. This is amonst the worse of the industry: AXTA underperforms 80.00% of its industry peers.
Industry RankSector Rank
Debt/Equity 1.64
Debt/FCF 8.4
Altman-Z 2.39
ROIC/WACC1.21
WACC8.65%
AXTA Yearly LT Debt VS Equity VS FCFAXTA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B

2.3 Liquidity

AXTA has a Current Ratio of 2.12. This indicates that AXTA is financially healthy and has no problem in meeting its short term obligations.
AXTA has a Current ratio (2.12) which is comparable to the rest of the industry.
A Quick Ratio of 1.53 indicates that AXTA should not have too much problems paying its short term obligations.
AXTA's Quick ratio of 1.53 is fine compared to the rest of the industry. AXTA outperforms 67.06% of its industry peers.
Industry RankSector Rank
Current Ratio 2.12
Quick Ratio 1.53
AXTA Yearly Current Assets VS Current LiabilitesAXTA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B 2B 2.5B

5

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 37.43% over the past year.
The Earnings Per Share has been growing slightly by 4.47% on average over the past years.
Looking at the last year, AXTA shows a small growth in Revenue. The Revenue has grown by 0.96% in the last year.
Measured over the past years, AXTA shows a small growth in Revenue. The Revenue has been growing by 3.31% on average per year.
EPS 1Y (TTM)37.43%
EPS 3Y10.28%
EPS 5Y4.47%
EPS Q2Q%22.92%
Revenue 1Y (TTM)0.96%
Revenue growth 3Y6.11%
Revenue growth 5Y3.31%
Sales Q2Q%-2.47%

3.2 Future

Based on estimates for the next years, AXTA will show a quite strong growth in Earnings Per Share. The EPS will grow by 10.63% on average per year.
Based on estimates for the next years, AXTA will show a small growth in Revenue. The Revenue will grow by 1.58% on average per year.
EPS Next Y15.01%
EPS Next 2Y12.49%
EPS Next 3Y11.98%
EPS Next 5Y10.63%
Revenue Next Year0.5%
Revenue Next 2Y1.96%
Revenue Next 3Y2.4%
Revenue Next 5Y1.58%

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
AXTA Yearly Revenue VS EstimatesAXTA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 1B 2B 3B 4B 5B
AXTA Yearly EPS VS EstimatesAXTA Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 1 2 3

7

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 12.25, AXTA is valued correctly.
Based on the Price/Earnings ratio, AXTA is valued a bit cheaper than 78.82% of the companies in the same industry.
The average S&P500 Price/Earnings ratio is at 26.31. AXTA is valued rather cheaply when compared to this.
Based on the Price/Forward Earnings ratio of 10.16, the valuation of AXTA can be described as reasonable.
Compared to the rest of the industry, the Price/Forward Earnings ratio of AXTA indicates a somewhat cheap valuation: AXTA is cheaper than 71.76% of the companies listed in the same industry.
AXTA is valuated cheaply when we compare the Price/Forward Earnings ratio to 22.13, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 12.25
Fwd PE 10.16
AXTA Price Earnings VS Forward Price EarningsAXTA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of AXTA indicates a somewhat cheap valuation: AXTA is cheaper than 65.88% of the companies listed in the same industry.
AXTA's Price/Free Cash Flow ratio is a bit cheaper when compared to the industry. AXTA is cheaper than 76.47% of the companies in the same industry.
Industry RankSector Rank
P/FCF 15.46
EV/EBITDA 8.52
AXTA Per share dataAXTA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 10 15 20

4.3 Compensation for Growth

AXTA's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
The excellent profitability rating of AXTA may justify a higher PE ratio.
PEG (NY)0.82
PEG (5Y)2.74
EPS Next 2Y12.49%
EPS Next 3Y11.98%

0

5. Dividend

5.1 Amount

AXTA does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

AXALTA COATING SYSTEMS LTD

NYSE:AXTA (6/13/2025, 6:40:00 PM)

After market: 28.79 0 (0%)

28.79

-1.37 (-4.54%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryChemicals
Earnings (Last)05-07 2025-05-07/bmo
Earnings (Next)07-30 2025-07-30/amc
Inst Owners100.95%
Inst Owner Change3.08%
Ins Owners0.28%
Ins Owner Change5.8%
Market Cap6.29B
Analysts77.78
Price Target41.32 (43.52%)
Short Float %2.32%
Short Ratio2.01
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)10.72%
Min EPS beat(2)6.38%
Max EPS beat(2)15.06%
EPS beat(4)4
Avg EPS beat(4)10.9%
Min EPS beat(4)6.38%
Max EPS beat(4)15.06%
EPS beat(8)6
Avg EPS beat(8)7.65%
EPS beat(12)9
Avg EPS beat(12)6.43%
EPS beat(16)12
Avg EPS beat(16)6.55%
Revenue beat(2)0
Avg Revenue beat(2)-2.88%
Min Revenue beat(2)-4.18%
Max Revenue beat(2)-1.58%
Revenue beat(4)0
Avg Revenue beat(4)-2.27%
Min Revenue beat(4)-4.18%
Max Revenue beat(4)-1.17%
Revenue beat(8)0
Avg Revenue beat(8)-2.27%
Revenue beat(12)2
Avg Revenue beat(12)-1.59%
Revenue beat(16)4
Avg Revenue beat(16)-1.15%
PT rev (1m)-1.52%
PT rev (3m)-8.21%
EPS NQ rev (1m)-5.78%
EPS NQ rev (3m)-6.24%
EPS NY rev (1m)1.57%
EPS NY rev (3m)-0.49%
Revenue NQ rev (1m)-2.37%
Revenue NQ rev (3m)-2.86%
Revenue NY rev (1m)-0.3%
Revenue NY rev (3m)-1.28%
Valuation
Industry RankSector Rank
PE 12.25
Fwd PE 10.16
P/S 1.2
P/FCF 15.46
P/OCF 11.08
P/B 3.03
P/tB N/A
EV/EBITDA 8.52
EPS(TTM)2.35
EY8.16%
EPS(NY)2.83
Fwd EY9.85%
FCF(TTM)1.86
FCFY6.47%
OCF(TTM)2.6
OCFY9.03%
SpS23.99
BVpS9.5
TBVpS-3.42
PEG (NY)0.82
PEG (5Y)2.74
Profitability
Industry RankSector Rank
ROA 6.06%
ROE 21.63%
ROCE 13.57%
ROIC 10.48%
ROICexc 11.57%
ROICexgc 23.73%
OM 15.73%
PM (TTM) 8.56%
GM 34.36%
FCFM 7.76%
ROA(3y)3.93%
ROA(5y)3.43%
ROE(3y)16.37%
ROE(5y)15.06%
ROIC(3y)7.99%
ROIC(5y)7.07%
ROICexc(3y)8.98%
ROICexc(5y)8.17%
ROICexgc(3y)18.89%
ROICexgc(5y)17.47%
ROCE(3y)10.36%
ROCE(5y)9.19%
ROICexcg growth 3Y10.83%
ROICexcg growth 5Y5.46%
ROICexc growth 3Y13.92%
ROICexc growth 5Y4.88%
OM growth 3Y8.8%
OM growth 5Y3.79%
PM growth 3Y7.44%
PM growth 5Y5.93%
GM growth 3Y1.74%
GM growth 5Y-0.48%
F-Score8
Asset Turnover0.71
Health
Industry RankSector Rank
Debt/Equity 1.64
Debt/FCF 8.4
Debt/EBITDA 3.07
Cap/Depr 57.09%
Cap/Sales 3.07%
Interest Coverage 250
Cash Conversion 51.31%
Profit Quality 90.65%
Current Ratio 2.12
Quick Ratio 1.53
Altman-Z 2.39
F-Score8
WACC8.65%
ROIC/WACC1.21
Cap/Depr(3y)49.94%
Cap/Depr(5y)42.77%
Cap/Sales(3y)2.8%
Cap/Sales(5y)2.67%
Profit Quality(3y)116.56%
Profit Quality(5y)173.32%
High Growth Momentum
Growth
EPS 1Y (TTM)37.43%
EPS 3Y10.28%
EPS 5Y4.47%
EPS Q2Q%22.92%
EPS Next Y15.01%
EPS Next 2Y12.49%
EPS Next 3Y11.98%
EPS Next 5Y10.63%
Revenue 1Y (TTM)0.96%
Revenue growth 3Y6.11%
Revenue growth 5Y3.31%
Sales Q2Q%-2.47%
Revenue Next Year0.5%
Revenue Next 2Y1.96%
Revenue Next 3Y2.4%
Revenue Next 5Y1.58%
EBIT growth 1Y40.4%
EBIT growth 3Y15.45%
EBIT growth 5Y7.24%
EBIT Next Year37.35%
EBIT Next 3Y15.1%
EBIT Next 5Y11.01%
FCF growth 1Y199.05%
FCF growth 3Y-0.08%
FCF growth 5Y-1.09%
OCF growth 1Y98.67%
OCF growth 3Y1.03%
OCF growth 5Y0.1%